Categories: Uncategorized

Centre writes to States/UTS to increase the Interval between two doses of COVISHIELD to 6-8 weeks

Centre has written to States/UTs to Increase the Interval between two doses of COVISHIELD to 6-8 weeks based on NTAGI and NEGVAC Recommendation.

The gap between two doses of the Covishield vaccine should be increased from 28 days to 6-8 weeks for better results immediately , the government has written to states and Union Territories.

The revised guidelines are only for Serum Institute of India’s Covishield which is developed by Oxford AstraZeneca.

“In view of the emerging scientific evidence, the interval between two doses of a specific COVID-19 vaccine, Covishiled has been revised by the National Technical Advisory Group on Immunization(NTAGI) and subsequently by National Expert Group on Vaccine Administartion for COVID-19 ,” the letter said.

According to the earlier guidelines issued by the Health Ministry was two doses of vaccine needed to be taken 28 days for both the vaccines.

AddThis Website Tools
Medically Speaking Team

Recent Posts

India’s Immunisation Coverage Soars from 73% to 95% in Two Years

Immunisation plays a crucial role in protecting children from life-threatening diseases. In the past two…

10 hours ago

Mounjaro vs. Ozempic: Which Is Safer for Weight Loss?

In recent years, new diabetes and weight loss medications have sparked widespread interest, particularly among…

11 hours ago

Nutraceuticals in India: Rising Popularity and Future Potential

Nutraceuticals, a fusion of "nutrition" and "pharmaceuticals," have emerged as a significant force in the…

12 hours ago

Statins and Ezetimibe: A Life-Saving Cholesterol-Lowering Combination

Heart disease remains one of the leading causes of death worldwide. For years, statins have…

12 hours ago

SARS-CoV-2: Still Circulating but Weaker, Say Experts

Five years after the COVID-19 pandemic brought the world to a standstill, the SARS-CoV-2 virus…

12 hours ago

Mounjaro Launched in India: Price & Impact on Diabetes and Obesity

Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…

2 days ago